The utility of dynamic MRI in differentiating the hormone-producing ability of pituitary adenomas.


Journal

Japanese journal of radiology
ISSN: 1867-108X
Titre abrégé: Jpn J Radiol
Pays: Japan
ID NLM: 101490689

Informations de publication

Date de publication:
Aug 2021
Historique:
received: 24 01 2021
accepted: 09 04 2021
pubmed: 22 4 2021
medline: 7 10 2021
entrez: 21 4 2021
Statut: ppublish

Résumé

To investigate the relationship between dynamic magnetic resonance imaging (MRI) findings and hormonal activity in pituitary adenomas. We retrospectively evaluated the dynamic MRI findings in 244 patients with pathologically confirmed pituitary adenomas and a diagnosis of clinically active prolactin (PRL)-producing adenomas. Among the 244 pituitary adenomas, 55, 16, 6, and 4 produced growth hormone (GH), PRL, adrenocorticotropic hormone, and thyroid-stimulating hormone, respectively, while 163 were non-functioning (NF) adenomas. For each adenoma, we calculated the washout rate (WR) and early (EER) and delayed (DER) tumour-to-normal-tissue enhancement ratios. The respective mean values of the WR, EER, and DER were 9.4%, 75.2%, and 64.5% for GH-producing adenomas; 6.2%, 117.1%, and 106.2% for PRL-producing adenomas; and 5.4%, 116.7%, and 108.7% for NF adenomas. GH-producing adenomas had significantly lower EER and DER values than PRL-producing (P < 0.001) and NF adenomas (P < 0.001). In ROC analysis of GH-producing and non-GH-producing adenomas, the areas under the curves of WR, EER, and DER were 0.593, 0.825, and 0.857, respectively. There are differences in dynamic MRI features between GH-producing and non-GH-producing adenomas, which suggests that EER and DER may be useful for diagnosing GH-producing adenomas.

Identifiants

pubmed: 33881731
doi: 10.1007/s11604-021-01121-9
pii: 10.1007/s11604-021-01121-9
pmc: PMC8338864
doi:

Substances chimiques

Prolactin 9002-62-4

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

741-748

Informations de copyright

© 2021. The Author(s).

Références

Clin Endocrinol (Oxf). 2015 Feb;82(2):267-73
pubmed: 24801354
Radiology. 2003 Aug;228(2):533-8
pubmed: 12819334
AJNR Am J Neuroradiol. 2017 Jun;38(6):1117-1121
pubmed: 28495945
Int J Endocrinol. 2014;2014:989574
pubmed: 25431591
J Clin Neurosci. 2002 Nov;9(6):659-63
pubmed: 12604278
Eur Radiol. 2005 Mar;15(3):543-8
pubmed: 15627195
AJR Am J Roentgenol. 1994 Sep;163(3):671-9
pubmed: 8079866
Int J Clin Exp Med. 2015 Aug 15;8(8):12898-905
pubmed: 26550206
Virchows Arch. 2001 Jun;438(6):595-602
pubmed: 11469692
Pituitary. 2017 Apr;20(2):201-209
pubmed: 27730456
Neuroradiology. 1997 Jun;39(6):394-9
pubmed: 9225316
J Anat. 2007 Nov;211(5):673-80
pubmed: 17784937
AJNR Am J Neuroradiol. 1994 Jan;15(1):101-8
pubmed: 8141039
Radiology. 1990 Oct;177(1):35-8
pubmed: 2399335
Neuroradiology. 1992;34(1):43-51
pubmed: 1553037

Auteurs

Taishi Amano (T)

Department of Diagnostic and Interventional Radiology, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan. taishi-amano@umin.ac.jp.

Tomohiko Masumoto (T)

Department of Diagnostic Radiology, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo, Japan.

Hiroyoshi Akutsu (H)

Department of Neurosurgery, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan.

Noriaki Sakamoto (N)

Department of Diagnostic Pathology, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan.

Sodai Hoshiai (S)

Department of Diagnostic and Interventional Radiology, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan.

Kensaku Mori (K)

Department of Diagnostic and Interventional Radiology, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan.

Takahito Nakajima (T)

Department of Diagnostic and Interventional Radiology, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH